India's Lupin joins stampede into injectable meds with Nanomi buyout

India's Lupin is staking a claim in sterile injectables, with a deal to buy the Netherlands-based drugmaker Nanomi. The market for injectable meds, which are complicated to develop and manufacture, has been heating up, and Lupin's buy is the third in the space in recent weeks. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.